CORMEDIX INC's ticker is and the CUSIP is 21900C958. A total of 3 filers reported holding CORMEDIX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,220 | -41.2% | 20,600 | -37.0% | 0.00% | – |
| Q2 2023 | $129,656 | +22.3% | 32,700 | +27.7% | 0.00% | – |
| Q1 2023 | $105,984 | +56.0% | 25,600 | +59.0% | 0.00% | – |
| Q4 2022 | $67,942 | +112.3% | 16,100 | +43.8% | 0.00% | – |
| Q3 2022 | $32,000 | -28.9% | 11,200 | -0.9% | 0.00% | – |
| Q2 2022 | $45,000 | +66.7% | 11,300 | +126.0% | 0.00% | – |
| Q1 2022 | $27,000 | +28.6% | 5,000 | +8.7% | 0.00% | – |
| Q4 2021 | $21,000 | -87.3% | 4,600 | -87.0% | 0.00% | – |
| Q3 2021 | $165,000 | -30.1% | 35,400 | +2.9% | 0.00% | – |
| Q2 2021 | $236,000 | +14.0% | 34,400 | +66.2% | 0.00% | – |
| Q1 2021 | $207,000 | +80.0% | 20,700 | +33.5% | 0.00% | – |
| Q4 2020 | $115,000 | +23.7% | 15,500 | +0.6% | 0.00% | – |
| Q3 2020 | $93,000 | -58.5% | 15,400 | -56.6% | 0.00% | -100.0% |
| Q2 2020 | $224,000 | +83.6% | 35,500 | +4.4% | 0.00% | 0.0% |
| Q1 2020 | $122,000 | -74.4% | 34,000 | -48.1% | 0.00% | -66.7% |
| Q4 2019 | $477,000 | +14.9% | 65,500 | +0.6% | 0.00% | 0.0% |
| Q3 2019 | $415,000 | -43.4% | 65,100 | -20.3% | 0.00% | -57.1% |
| Q2 2019 | $733,000 | -32.7% | 81,700 | -29.1% | 0.01% | -41.7% |
| Q1 2019 | $1,089,000 | – | 115,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 11,200 | $32,000 | 0.00% |
| SIMPLEX TRADING, LLC | 38,900 | $110,000 | 0.00% |